MeDirect Bank (Malta) plc would like to announce that we are accepting applications for anyone interested in the new bond issue by MM Star Malta Finance p.l.c. (the “Issuer”).
MM Star Malta Finance p.l.c. has announced the issue of €35,000,000 Secured bonds at 5.35% at a nominal value of €100 per bond, redeemable in 2029 – 2031 (the “Bond Issue”), following approval by the Listing Authority.
About MM Star Malta Finance p.l.c.
MM Star Malta Finance p.l.c. is the finance company for the MM Star Group, a subsidiary of Millemont Capital Partners—a London-based private equity real estate investment firm focused on sustainable hospitality assets in high-potential city locations.
The bond proceeds will be used to:
- Repay a bank facility used to acquire YOTEL Edinburgh
- Partially reimburse shareholder loans tied to the same transaction
Who is Millemont Capital Partners?
Millemont specialises in acquiring and repositioning lifestyle hotels across the UK and Europe. Their strategy is based on:
- Investing in income-generating hospitality assets in key urban markets
- Targeting value-add opportunities through active asset management and refurbishment
- Integrating sustainability practices to enhance long-term value
Bond Highlights
- Total Amount: €35,000,000
- Interest Rate: 5.35% annually
- Issue Price: €100 per bond
- Minimum Investment: €2,000 (and in multiples of €100)
- Redemption: Between 2029 and 2031
- Interest Payment Date: 27 June each year
- Security: The bond is secured against the YOTEL Edinburgh hotel
- Guarantor: MM Star HoldCo Ltd
Full details about this Bond Issue are set out in the Prospectus dated 27 May 2025 which can be found here.
MeDirect will be accepting applications from anyone, who is interested. All applications must be received by not later than 20 June 2025. In the event of over-subscription, the Issuer reserves the right to close the Offer Period before this date.
If you are interested in applying, please send us a Secure Mail or contact your Relationship Manager.
For further information, please call us on (+356) 2557 4400 or send an email to customerservice@medirect.com.mt.
The information set forth in this article is only for informative purposes and should not be construed as an offer to sell or solicitation of an offer to subscribe for or purchase any investment. The information provided is subject to change without notice and does not constitute investment advice or any guarantee of returns. Please consider the terms and conditions governing the relevant investment prior to making any investment decision. Investors should note that at worst they may lose all of their invested principal in the event of default, insolvency and/or bankruptcy of the relevant issue. The financial instruments discussed may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.
The financial instruments discussed are intended for retail clients, however, may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.
MeDirect Bank (Malta) plc has based this document on information obtained from sources it believes to be reliable but which have not been independently verified. MeDirect Bank (Malta) plc does not therefore provide any guarantees, representations or warranties. The value of any investment or income may go up as well as down and past performance is no guarantee of any future performance. When an investment is denominated in a currency other than your local or reporting currency, changes in exchange rates may have an adverse effect on your investment.
MeDirect Bank (Malta) plc, company registration number C34125, is licensed by the Malta Financial Services Authority under the Banking Act (Cap. 371) and the Investment Services Act (Cap. 370). This material shall not be reproduced in any way, whether in whole or in part. Any unauthorised disclosure, use or dissemination, either in whole or in part, of the material contained within is strictly prohibited.
